Research funder · United States
Congressionally Directed Medical Research Programs
Government organization in United States of America
- Grants since 2016
- 10.2k
- Awarded, last 5 years (where amounts are published)
- $6.5B
- Funded works, last 5 years
- 3 662
- Funded works, all time
- 7 320
Grants
2025–2029 · grant · OCRP
Development of GUAR-T as a Novel Class of Universal Cellular Immunotherapies for Ovarian Cancer
Sidi Chen · Yale University
2025–2029 · grant · ORP
Losartan to Improve Outcomes After Multiligament Knee Injury (LION Trial)
Cale Jacobs · Brigham And Women's Hospital, Inc.
2025–2027 · grant · TSCRP
Integrative Transcriptomic and Epigenomic Profiling of Subependymal Giant Cell Astrocytoma at Single-Cell Resolution
Anoop Patel · Duke University
2025–2029 · grant · OCRP
Targeting De Novo Pyrimidine Synthesis to Treat Ovarian Cancer
Qi-En Wang · The Ohio State University
2025–2027 · grant · RCRP
LAT1 as a Therapeutic and Diagnostic Marker in Malignant Peripheral Nerve Sheath Tumors
Angela Hirbe · Washington University in St. Louis
2025–2029 · grant · KCRP
Profilin1's Role in Chromophobe Renal Cell Carcinoma Mitochondria and Tumorigenesis
David Gau · University Of Pittsburgh-of The Commonwealth System Of Higher Ed.
2025–2028 · grant · PCRP
Novel Therapeutics Targeting BET-Mediated Oncogenesis in Lethal Prostate Cancer
Allen Gao · California, University Of, Davis
2025–2027 · grant · RCRP
Exploring a Novel Antibody-Drug Conjugate (ADC) Strategy to Block MYC Protein Production in Neuroblastoma (NB)
Hans Wendel · Sloan Kettering Institute For Cancer Research
2025–2027 · grant · PRMRP
Clinical Evaluation of 4-Aminopyridine in Hereditary Spinocerebellar Ataxia
Susan Perlman · California, University Of, Los Angeles
2025–2027 · grant · PCRP
Investigating ARHGEF2 in Promoting Neural Lineage Plasticity and Treatment Resistance in Advanced Prostate Cancer
Shu Ning · California, University Of, Davis
2025–2028 · grant · LCRP
A Precision-Medicine Approach to Targeting Acquired Therapeutic Resistance in RTK-Mutated NSCLC
Robert Kortum · Uniformed Services University Of The Health Sciences (usuhs)
2025–2029 · grant · BCRP
Prevention of Liver Metastasis by Defining Regulators of Tumor Dormancy, How They are Disrupted, and How to Reverse It
Lawrence Kushi · Kaiser Foundation Research Institute
2025–2026 · grant · PRMRP
Targeting Mutant Protein Degradation for Therapeutic Intervention of Genetic FSGS
Balaji Karthick Subramanian · Beth Israel Deaconess Medical Center, Boston
2025–2028 · grant · MSRP
Multidimensional Imaging Data-Driven Approach for Phenotyping Multiple Sclerosis
Pascal Sati · Cedars-Sinai Medical Center
2025–2026 · grant · PRMRP
Curcumin-QingDai (CurQD) in Combination With Vedolizumab Versus Vedolizumab Alone as Induction and Maintenance Therapy in Ulcerative Colitis
Ryan Ungaro · Icahn School of Medicine at Mount Sinai
2025–2029 · grant · BCRP
Defining Human Correlates of Super-Evasive Disseminated Tumor Cells, Their Pathological Relevance and How to Eradicate Them
Cyrus Ghajar · Fred Hutchinson Cancer Center
2025–2028 · grant · PCRP
Therapeutic Targeting of Aberrant mRNA Polyadenylation in Lethal Prostate Cancer
Scott Dehm · Minnesota, University Of, Twin Cities
2025–2027 · grant · LCRP
Bacterial Flagellin-Driven LINE-1 Retrotransposon Activation: A New Frontier in Lung Cancer Research
Dekai Zhang · Texas A&m University System Health Science Center, College Station
2025–2027 · grant · PCRP
To Investigate Tumor-Intrinsic Epigenetic Mechanisms Modulating Antitumor Immune Responses in Metastatic Prostate Cancer
Anindita Dutta · Icahn School of Medicine at Mount Sinai
2025–2028 · grant · NFRP
Understanding and Targeting Epigenetic Vulnerabilities in NF1-MPNST
Angela Hirbe · Washington University in St. Louis
2025–2029 · grant · PCRP
Disseminating the Interactive Support, Communication and Information (SCIPI) to Men With Localized Prostate Cancer: A Multisite Pilot Randomized Clinical Trial
Lixin Song · Texas, University Of, Health Science Center At San Antonio
2025–2028 · grant · KCRP
Quantifying Spatial Properties of Immunosuppressive Macrophages in Papillary Renal Cell Carcinoma
Mitchell Hayes · H. Lee Moffitt Cancer Center And Research Institute, At South Florida, University Of
2025–2028 · grant · PCARP
Rewiring Very Long Chain Fatty Acid Metabolism in Pancreatic Tumor-Associated Macrophages to Overcome KRAS-Targeted Therapy Resistance
Pingping Hou · Rutgers, New Jersey, State University Of
2025–2028 · grant · BCRP
Interplay Between Sensory Neurons and NK Cells During Breast Cancer Metastatic Dormancy
Lucas Ferrari De Andrade · Icahn School of Medicine at Mount Sinai
2025–2027 · grant · MSRP
Mapping the Multiple Sclerosis Prodrome: Symptoms, Diagnosis and Prognosis
Peter Alping · Karolinska Institutet
2025–2029 · grant · BCRP
A Multiantigen Vaccine (STEMVAC) for Adjuvant Treatment of Patients With Moderate or Extensive Residual Triple-Negative Breast Cancer
Kari Wisinski · Wisconsin, University Of, Madison
2025–2028 · grant · PRMRP
A Phase 2 Clinical Trial of SRX246 in Fragile X Syndrome (FXS)
Michael Brownstein · Azevan Pharmaceuticals (United States)
2025–2029 · grant · PRMRP
Pharmacological Treatment to Prevent Pediatric Hydrocephalus
Leandro Castaneyra-Ruiz · Children's Hospital, Orange County
2025–2027 · grant · RCRP
Targeting the ZER1 Ubiquitin Ligase for the Treatment of HPV+ Penile, Anal, and Vulvar Cancers
William Sellers · Broad Institute
2025–2027 · grant · RCRP
Targeting TIE2 as a Novel Strategy in VEGFR Inhibitor-Resistant Angiosarcoma
Donghee Lee · Florida, University Of
2025–2027 · grant · MSRP
Overlooked No More: The Impact of the Menstrual Cycle on Neuromuscular Function in Women With Multiple Sclerosis
Kristin Johnson · Colorado State University
2025–2027 · grant · RCRP
LNP-Based SNAs to Overcome Immunosuppression in Glioblastoma
Barry Labinger · Flashpoint Therapeutics, Inc.
2025–2029 · grant · KCRP
Targeting METTL3 to Overcome Drug Resistance in Metastatic Clear Cell Renal Cell Carcinoma
Dharam Kaushik · Methodist Hospital Research Institute, Houston, Tx
2025–2027 · grant · RCRP
Improving Chemotherapy Efficacy for Small Cell Carcinomas of the Bladder
Qiang Li · Health Research Inc., Roswell Park Division
2025–2027 · grant · ATRP
P15-1 Peptide Treatment for Cartilage Injuries and Post-Traumatic Osteoarthritis
Thorsten Kirsch · New York University
2025–2028 · grant · PRMRP
Bone Fracture-Induced Joint Bleeding and Posttraumatic Osteoarthritis
Clark Hung · Columbia University Irving Medical Center
2025–2028 · grant · DMDRP
Predicting Later Differential DMD Patient Quality of Life of Distinct Corticosteroid Regimens via Serum Proteome and Steroid Hormone Profiling
Utkarsh Dang · Carleton University
2025–2029 · grant · TBIPH
MDMA-Assisted Massed Exposure Therapy for PTSD
Jessica Maples-Keller · Emory University
2025–2027 · grant · PCARP
Axonal Guidance Molecule Neuropilin-2 (NRP2) Promotes Perineural Invasion (PNI) and Pain in PDAC Patients
Ashu Shah · Nebraska, University Of, Medical Center
2025–2026 · grant · ALSRP
A Novel Small Molecule Screening Approach for Direct and Selective Targeting of Repeat Expansion RNA in C9orf72 ALS
David Sparkman-Yager · Wayfinder Biosciences, Inc.